DNA-PK, Nuclear mTOR, and the Androgen Pathway in Prostate Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

DNA-PK, Nuclear mTOR, and the Androgen Pathway in Prostate Cancer

Published:2020-04 Issue:4 Volume:6 Page:337-347
ISSN:2405-8033
Container-title:Trends in Cancer
language:en
Short-container-title:Trends in Cancer

Author:

Giguère Vincent

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference82 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Androgen receptor signaling in the development of castration-resistant prostate cancer;Feng;Front. Oncol.,2019

3. Delineation of the androgen-regulated signaling pathways in prostate cancer facilitates the development of novel therapeutic approaches;Awad;Curr. Opin. Pharmacol.,2018

4. Systemic treatments for high-risk localized prostate cancer;Pignot;Nat. Rev. Urol.,2018

5. Integrative clinical genomics of advanced prostate cancer;Robinson;Cell,2015

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell sequencing revealed metabolic reprogramming and its transcription factor regulatory network in prostate cancer;Translational Oncology;2024-06

2. MALAT1 promotes FOXA1 degradation by competitively binding to miR-216a-5p and enhancing neuroendocrine differentiation in prostate cancer;Translational Oncology;2024-01

3. Canonical and Nuclear mTOR Specify Distinct Transcriptional Programs in Androgen-Dependent Prostate Cancer Cells;Molecular Cancer Research;2023-10-26

4. Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer;Molecular Cancer Research;2023-07-06

5. Function-oriented synthesis of Imidazo[1,2-a]pyrazine and Imidazo[1,2-b]pyridazine derivatives as potent PI3K/mTOR dual inhibitors;European Journal of Medicinal Chemistry;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3